✦ LIBER ✦

A 3-Year Follow-Up of Pre-Emptive vs Deferred Treatment of Cytomegalovirus Disease in Renal Transplantation

✍ Scribed by Dr Mark A. Schnitzler, Troy G. Metheney, Jose F. Rueda, Robert S. Woodward, Jeffrey A. Lowell, Gary G. Singer, Surendra Shenoy, Todd K. Howard, Gregory A. Storch, Daniel C. Brennan

Book ID: 119929538
Publisher: Springer International Publishing AG
Year: 2000
Tongue: English
Weight: 177 KB
Volume: 19
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200019050-00007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mycophenolate mofetil in the treatment o

Mycophenolate mofetil in the treatment of chronic rejection in renal transplantation: 3-year follow-up

✍ I.L Noronha; A.C Oliveira; H Abensur; J.E Romão Jr; M.R.T Araújo; R Zatz 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 59 KB

175: Usefulness of pre-emptive therapy f

175: Usefulness of pre-emptive therapy for cytomegalovirus disease in the first year after heart transplantation: A study of 236 patients

✍ M.J. Paniagua; M.G. Crespo-Leiro; J. Muniz; R. Marzoa; C. Naya; A. Canizares; P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

CYCLOSPORIN IN CADAVERIC RENAL TRANSPLAN

CYCLOSPORIN IN CADAVERIC RENAL TRANSPLANTATION: 3-YEAR FOLLOW-UP OF A EUROPEAN MULTICENTRE TRIAL

✍ CALNE, R 📂 Article 📅 1985 🏛 The Lancet 🌐 English ⚖ 155 KB

A prospective, randomized trial of tacro

A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up

✍ R Shapiro; M.L Jordan; V.P Scantlebury; C Vivas; J.W Marsh; J McCauley; J Johnst 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 49 KB

ALG versus OKT3 for treatment of steroid

ALG versus OKT3 for treatment of steroid-resistant rejection in renal transplantation: ten-year follow-up results of a randomized trial

✍ D.L Stippel; W Arns; M Pollok; K.T.E Beckurts; U.J Hesse; A.H Hölscher 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 66 KB

IVIG and rituximab for treatment of chro

IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up

✍ Heiko Billing; Susanne Rieger; Caner Süsal; Rüdiger Waldherr; Gerhard Opelz; Elk 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 326 KB